Versican accumulates in vascular lesions in pulmonary arterial hypertension

Abstract. Pulmonary arterial hypertension (PAH) is a lethal condition for which there is no effective curative pharmacotherapy. PAH is characterized by vasoconstriction, wall thickening of pulmonary arteries, and increased vascular resistance. Versican is a chondroitin sulfate proteoglycan in the va...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pulm Circ
Päätekijät: Chang, Ya-Ting, Chan, Christina K., Eriksson, Inger, Johnson, Pamela Y., Cao, Xiaofang, Westöö, Christian, Norvik, Christian, Andersson-Sjöland, Annika, Westergren-Thorsson, Gunilla, Johansson, Staffan, Hedin, Ulf, Kjellén, Lena, Wight, Thomas N., Tran-Lundmark, Karin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: University of Chicago Press 2016
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5019088/
https://ncbi.nlm.nih.gov/pubmed/27683612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/686994
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia